About 5 results found for searched term "SC912" (0.054 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5858 | Parecoxib | COX |
| SC-69124, Valus-P, Vorth-P | ||
| Parecoxib (SC 69124) is a highly selective and orally active COX-2 inhibitor, the proagent of Valdecoxib (HY-15762). Parecoxib Sodium is a nonsteroidal anti-inflammatory agent (NSAID) and inhibits prostaglandin (PG) synthesis. | ||
| M5859 | Parecoxib Sodium | COX |
| SC 69124A | ||
| Parecoxib Sodium (SC 69124A) is a potent and highly selective and orally active COX-2 inhibitor. Parecoxib Sodium is a nonsteroidal anti-inflammatory agent (NSAID) and inhibits prostaglandin (PG) synthesis. | ||
| M13791 | Lucigenin | Fluorescent Dye |
| NSC-151912; L-6868 | ||
| Lucigenin(L-6868; NSC-151912) is a chemiluminescent probe used to indicate the presence of endogenously generated superoxide anion radicals in cells. | ||
| M28943 | Sangivamycin | PKC |
| NSC 65346; BA-90912 | ||
| Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers. | ||
| M57283 | SC912 | Androgen Receptor |
| SC-912 | ||
| SC912 is a potent and selective AR-V7 inhibitor with IC50 of 0.36 μM. SC912 binds directly to AR-FL and AR-V7 proteins, inhibites nuclear localization and chromatin binding capabilities. SC912 exerts anticancer activity through inhibition of proliferation, induction of cell cycle arrest and apoptosis. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
